MED19
Mediator complex subunit 19 (Med19) is a protein that in humans is encoded by the MED19 gene. [5]
| MED19 | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Identifiers | |||||||||||||||||||||||||
| Aliases | MED19, DT2P1G7, LCMR1, MED19AS, mediator complex subunit 19 | ||||||||||||||||||||||||
| External IDs | OMIM: 612385 MGI: 1914234 HomoloGene: 14684 GeneCards: MED19 | ||||||||||||||||||||||||
| |||||||||||||||||||||||||
| |||||||||||||||||||||||||
| Orthologs | |||||||||||||||||||||||||
| Species | Human | Mouse | |||||||||||||||||||||||
| Entrez | |||||||||||||||||||||||||
| Ensembl | |||||||||||||||||||||||||
| UniProt | |||||||||||||||||||||||||
| RefSeq (mRNA) | |||||||||||||||||||||||||
| RefSeq (protein) | |||||||||||||||||||||||||
| Location (UCSC) | Chr 11: 57.7 – 57.71 Mb | Chr 2: 84.68 – 84.69 Mb | |||||||||||||||||||||||
| PubMed search | [3] | [4] | |||||||||||||||||||||||
| Wikidata | |||||||||||||||||||||||||
| |||||||||||||||||||||||||
Function
The protein encoded by this gene is a subunit of the Mediator complex, which binds to gene-specific regulatory factors and provides support for the basal RNA polymerase II transcription machinery. This gene has been implicated in the growth of several types of cancer, and inhibition of its expression inhibits the growth and spread of these cancers. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2015].
See also
References
- GRCh38: Ensembl release 89: ENSG00000156603 - Ensembl, May 2017
- GRCm38: Ensembl release 89: ENSMUSG00000027080 - Ensembl, May 2017
- "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- "Entrez Gene: Mediator complex subunit 19". Retrieved 2018-02-06.
Further reading
- Ding N, Tomomori-Sato C, Sato S, Conaway RC, Conaway JW, Boyer TG (2009). "MED19 and MED26 are synergistic functional targets of the RE1 silencing transcription factor in epigenetic silencing of neuronal gene expression". J. Biol. Chem. 284 (5): 2648–56. doi:10.1074/jbc.M806514200. PMC 2631966. PMID 19049968.
- Li LH, He J, Hua D, Guo ZJ, Gao Q (2011). "Lentivirus-mediated inhibition of Med19 suppresses growth of breast cancer cells in vitro". Cancer Chemother. Pharmacol. 68 (1): 207–15. doi:10.1007/s00280-010-1468-9. PMID 20890603. S2CID 19531562.
- Chen L, Liang Z, Tian Q, Li C, Ma X, Zhang Y, Yang Z, Wang P, Li Y (2011). "Overexpression of LCMR1 is significantly associated with clinical stage in human NSCLC". J. Exp. Clin. Cancer Res. 30: 18. doi:10.1186/1756-9966-30-18. PMC 3045976. PMID 21306606.
- Zou SW, Ai KX, Wang ZG, Yuan Z, Yan J, Zheng Q (2011). "The role of Med19 in the proliferation and tumorigenesis of human hepatocellular carcinoma cells". Acta Pharmacol. Sin. 32 (3): 354–60. doi:10.1038/aps.2010.223. PMC 4002777. PMID 21372827.
- Zhang H, Jiang H, Wang W, Gong J, Zhang L, Chen Z, Ding Q (2012). "Expression of Med19 in bladder cancer tissues and its role on bladder cancer cell growth". Urol. Oncol. 30 (6): 920–7. doi:10.1016/j.urolonc.2010.10.003. PMID 21478038.
- Sun M, Jiang R, Li JD, Luo SL, Gao HW, Jin CY, Shi DL, Wang CG, Wang B, Zhang XY (2011). "MED19 promotes proliferation and tumorigenesis of lung cancer". Mol. Cell. Biochem. 355 (1–2): 27–33. doi:10.1007/s11010-011-0835-0. PMID 21519921. S2CID 24675844.
- Wang T, Hao L, Feng Y, Wang G, Qin D, Gu G (2011). "Knockdown of MED19 by lentivirus-mediated shRNA in human osteosarcoma cells inhibits cell proliferation by inducing cell cycle arrest in the G0/G1 phase". Oncol. Res. 19 (5): 193–201. doi:10.3727/096504011x12970940207760. PMID 21542455.
- Ji-Fu E, Xing JJ, Hao LQ, Fu CG (2012). "Suppression of lung cancer metastasis-related protein 1 (LCMR1) inhibits the growth of colorectal cancer cells". Mol. Biol. Rep. 39 (4): 3675–81. doi:10.1007/s11033-011-1142-2. PMID 21732059. S2CID 1788019.
- Cui X, Xu D, Lv C, Qu F, He J, Chen M, Liu Y, Gao Y, Che J, Yao Y, Yu H (2011). "Suppression of MED19 expression by shRNA induces inhibition of cell proliferation and tumorigenesis in human prostate cancer cells". BMB Rep. 44 (8): 547–52. doi:10.5483/bmbrep.2011.44.8.547. PMID 21871180.
This article incorporates text from the United States National Library of Medicine, which is in the public domain.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.